Dynacirc CR (Isradipine) - Summary

DYNACIRC CR SUMMARY

DynaCirc CR^®(isradipine)Controlled Release Tablets

DynaCirc CR® contains isradipine, a calcium antagonist. It is available for once-daily oral administration as a controlled release 5 mg and 10 mg tablet for DynaCirc CR® (isradipine). DynaCirc CR® is a registered trademark for isradipine GITS (Gastrointestinal Therapeutic System) tablets.

DynaCirc CR® (isradipine) is indicated in the management of hypertension. It may be used alone or concurrently with thiazide-type diuretics.

See all Dynacirc CR indications & dosage >>

DYNACIRC CR NEWS HIGHLIGHTS

Published Studies Related to Dynacirc CR (Isradipine)

Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. [2005.12]

Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. [2005.06]

Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. [2005.03]

Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals. [2005.01]

Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. [2004.05.03]

more >>

Clinical Trials Related to Dynacirc CR (Isradipine)

Parkinson's Disease Isradipine Safety Study [Recruiting]

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. [Completed]

An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers [Active, not recruiting]

Drug Discrimination in Methadone-Maintained Humans [Recruiting]

Drug Discrimination in Methadone-Maintained Humans Study 2 [Recruiting]

more >>